Biotech

All Articles

AC Immune views 'site' prospective in Alzheimer's drug records

.After greater than two decades of focus on neurodegenerative ailments, Swiss biotech a/c Immune sys...

GSK drops ph. 2 HPV vaccine over lack of best-in-class possible

.GSK has actually broken up a period 2 human papillomavirus (HPV) vaccine coming from its own pipe a...

OS Therapies refiles $6M IPO to money HER2 medicine, preclinical ADCs

.Operating system Therapies will detail on the NYSE American stock exchange this morning through a $...

ALX's waning CD47 reaction fee delivers supply spiraling down

.ALX Oncology's phase 2 gastric cancer cells action rate has damaged. After finding its CD47 blocker...

Ionis centers eye illness coming from intendeds of Roche-partnered prospect after data disappoint

.An Additional of Ionis Pharmaceuticals' crucial midphase readouts has fallen short of expectations,...

Biogen's CEO pointed out no dangerous deals in 2023. He prepares to become bold

.While Biogen's pharma peers are actually looking for late-stage possessions along with little bit o...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Bio has been actually a biotech searching for a pipeline after it ditched its lead resources...

Biogen ignores Denali Alzheimer's collab

.Biogen has actually handed back civil liberties to a very early Alzheimer's disease system to Denal...

Takeda touches brand-new head of US oncology service-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of considerable leadership hirings, firings a...

Vertex, hammered through AATD once again, falls 2 resources on throw out pile

.Tip's attempt to treat an unusual hereditary health condition has attacked an additional trouble. T...